Cargando…
An advanced glioma cell invasion assay based on organotypic brain slice cultures
BACKGROUND: The poor prognosis for glioblastoma patients is caused by the diffuse infiltrative growth pattern of the tumor. Therefore, the molecular and cellular processes underlying cell migration continue to be a major focus of glioblastoma research. Emerging evidence supports the concept that the...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789681/ https://www.ncbi.nlm.nih.gov/pubmed/29378533 http://dx.doi.org/10.1186/s12885-018-4007-4 |
_version_ | 1783296332436340736 |
---|---|
author | Eisemann, Tanja Costa, Barbara Strelau, Jens Mittelbronn, Michel Angel, Peter Peterziel, Heike |
author_facet | Eisemann, Tanja Costa, Barbara Strelau, Jens Mittelbronn, Michel Angel, Peter Peterziel, Heike |
author_sort | Eisemann, Tanja |
collection | PubMed |
description | BACKGROUND: The poor prognosis for glioblastoma patients is caused by the diffuse infiltrative growth pattern of the tumor. Therefore, the molecular and cellular processes underlying cell migration continue to be a major focus of glioblastoma research. Emerging evidence supports the concept that the tumor microenvironment has a profound influence on the functional properties of tumor cells. Accordingly, substantial effort must be devoted to move from traditional two-dimensional migration assays to three-dimensional systems that more faithfully recapitulate the complex in vivo tumor microenvironment. METHODS: In order to mimic the tumor microenvironment of adult gliomas, we used adult organotypic brain slices as an invasion matrix for implanted, fluorescently labeled tumor spheroids. Cell invasion was imaged by confocal or epi-fluorescence microscopy and quantified by determining the average cumulative sprout length per spheroid. The tumor microenvironment was manipulated by treatment of the slice with small molecule inhibitors or using different genetically engineered mouse models as donors. RESULTS: Both epi-fluorescence and confocal microscopy were applied to precisely quantify cell invasion in this ex vivo approach. Usage of a red-emitting membrane dye in addition to tissue clearing drastically improved epi-fluorescence imaging. Preparation of brain slices from of a genetically engineered mouse with a loss of a specific cell surface protein resulted in significantly impaired tumor cell invasion. Furthermore, jasplakinolide treatment of either tumor cells or brain slice significantly reduced tumor cell invasion. CONCLUSION: We present an optimized invasion assay that closely reflects in vivo invasion by the implantation of glioma cells into organotypic adult brain slice cultures with a preserved cytoarchitecture. The diversity of applications including manipulation of the tumor cells as well as the microenvironment, permits the investigation of rate limiting factors of cell migration in a reliable context. This model will be a valuable tool for the discovery of the molecular mechanisms underlying glioma cell invasion and, ultimately, the development of novel therapeutic strategies. |
format | Online Article Text |
id | pubmed-5789681 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-57896812018-02-08 An advanced glioma cell invasion assay based on organotypic brain slice cultures Eisemann, Tanja Costa, Barbara Strelau, Jens Mittelbronn, Michel Angel, Peter Peterziel, Heike BMC Cancer Technical Advance BACKGROUND: The poor prognosis for glioblastoma patients is caused by the diffuse infiltrative growth pattern of the tumor. Therefore, the molecular and cellular processes underlying cell migration continue to be a major focus of glioblastoma research. Emerging evidence supports the concept that the tumor microenvironment has a profound influence on the functional properties of tumor cells. Accordingly, substantial effort must be devoted to move from traditional two-dimensional migration assays to three-dimensional systems that more faithfully recapitulate the complex in vivo tumor microenvironment. METHODS: In order to mimic the tumor microenvironment of adult gliomas, we used adult organotypic brain slices as an invasion matrix for implanted, fluorescently labeled tumor spheroids. Cell invasion was imaged by confocal or epi-fluorescence microscopy and quantified by determining the average cumulative sprout length per spheroid. The tumor microenvironment was manipulated by treatment of the slice with small molecule inhibitors or using different genetically engineered mouse models as donors. RESULTS: Both epi-fluorescence and confocal microscopy were applied to precisely quantify cell invasion in this ex vivo approach. Usage of a red-emitting membrane dye in addition to tissue clearing drastically improved epi-fluorescence imaging. Preparation of brain slices from of a genetically engineered mouse with a loss of a specific cell surface protein resulted in significantly impaired tumor cell invasion. Furthermore, jasplakinolide treatment of either tumor cells or brain slice significantly reduced tumor cell invasion. CONCLUSION: We present an optimized invasion assay that closely reflects in vivo invasion by the implantation of glioma cells into organotypic adult brain slice cultures with a preserved cytoarchitecture. The diversity of applications including manipulation of the tumor cells as well as the microenvironment, permits the investigation of rate limiting factors of cell migration in a reliable context. This model will be a valuable tool for the discovery of the molecular mechanisms underlying glioma cell invasion and, ultimately, the development of novel therapeutic strategies. BioMed Central 2018-01-30 /pmc/articles/PMC5789681/ /pubmed/29378533 http://dx.doi.org/10.1186/s12885-018-4007-4 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Technical Advance Eisemann, Tanja Costa, Barbara Strelau, Jens Mittelbronn, Michel Angel, Peter Peterziel, Heike An advanced glioma cell invasion assay based on organotypic brain slice cultures |
title | An advanced glioma cell invasion assay based on organotypic brain slice cultures |
title_full | An advanced glioma cell invasion assay based on organotypic brain slice cultures |
title_fullStr | An advanced glioma cell invasion assay based on organotypic brain slice cultures |
title_full_unstemmed | An advanced glioma cell invasion assay based on organotypic brain slice cultures |
title_short | An advanced glioma cell invasion assay based on organotypic brain slice cultures |
title_sort | advanced glioma cell invasion assay based on organotypic brain slice cultures |
topic | Technical Advance |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789681/ https://www.ncbi.nlm.nih.gov/pubmed/29378533 http://dx.doi.org/10.1186/s12885-018-4007-4 |
work_keys_str_mv | AT eisemanntanja anadvancedgliomacellinvasionassaybasedonorganotypicbrainslicecultures AT costabarbara anadvancedgliomacellinvasionassaybasedonorganotypicbrainslicecultures AT strelaujens anadvancedgliomacellinvasionassaybasedonorganotypicbrainslicecultures AT mittelbronnmichel anadvancedgliomacellinvasionassaybasedonorganotypicbrainslicecultures AT angelpeter anadvancedgliomacellinvasionassaybasedonorganotypicbrainslicecultures AT peterzielheike anadvancedgliomacellinvasionassaybasedonorganotypicbrainslicecultures AT eisemanntanja advancedgliomacellinvasionassaybasedonorganotypicbrainslicecultures AT costabarbara advancedgliomacellinvasionassaybasedonorganotypicbrainslicecultures AT strelaujens advancedgliomacellinvasionassaybasedonorganotypicbrainslicecultures AT mittelbronnmichel advancedgliomacellinvasionassaybasedonorganotypicbrainslicecultures AT angelpeter advancedgliomacellinvasionassaybasedonorganotypicbrainslicecultures AT peterzielheike advancedgliomacellinvasionassaybasedonorganotypicbrainslicecultures |